Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Extension Study for Patients Previously Treated With ARQ 501.

Trial Profile

An Extension Study for Patients Previously Treated With ARQ 501.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 27 Feb 2013

At a glance

  • Drugs Beta lapachone (Primary)
  • Indications Cancer
  • Focus Therapeutic Use
  • Sponsors ArQule
  • Most Recent Events

    • 08 Jan 2009 Planned patient number added (1) as reported by ClinicalTrials.gov.
    • 08 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 13 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top